Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metallic nanostructure-based aptasensors for robust detection of proteins. | Nanoscale Adv | 2024 | 38298588 | PubTator, text mining | PubMed |
| Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report. | Diagn Pathol | 2024 | 38297350 | PubTator, text mining | PubMed |
| Diagnosis and Treatment of Metastatic Colon Cancer in Pregnancy First Presenting as Multiple Liver Masses: A Case Report. | Cureus | 2024 | 38293677 | PubTator, text mining | PubMed |
| FH deficient uterine leiomyomas-a case series. | Heliyon | 2024 | 38293425 | PubTator, text mining | PubMed |
| Multiomic analysis implicates nuclear hormone receptor signalling in clustering epilepsy. | Transl Psychiatry | 2024 | 38280856 | PubTator, text mining | PubMed |
| Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells. | Cancer Immunol Immunother | 2024 | 38280067 | PubTator, text mining | PubMed |
| Glutaredoxin 2 Protein (Grx2) as an Independent Prognostic Factor Associated with the Survival of Colon Adenocarcinoma Patients. | Int J Mol Sci | 2024 | 38256132 | PubTator, text mining | PubMed |
| Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy. | Cancers (Basel) | 2024 | 38254874 | PubTator, text mining | PubMed |
| Well-Differentiated Papillary Mesothelial Tumor of the Scrotum with Suspicious Invasion. | Diagnostics (Basel) | 2024 | 38248046 | PubTator, text mining | PubMed |
| Preoperative IL-8 levels as prognostic indicators of overall survival: an extended follow-up in a prospective cohort with colorectal liver metastases. | BMC Cancer | 2024 | 38233759 | PubTator, text mining | PubMed |
| Advanced function, design and application of skin substitutes for skin regeneration. | Mater Today Bio | 2024 | 38223459 | PubTator, text mining | PubMed |
| Diagnostic Methods in Forensic Pathology: Autoptic Findings and Immunohistochemical Study in Cases of Sudden Death Due to a Colloid Cyst of the Third Ventricle. | Diagnostics (Basel) | 2024 | 38201409 | PubTator, text mining | PubMed |
| Cancer vaccines in the clinic. | Bioeng Transl Med | 2024 | 38193112 | PubTator, text mining | PubMed |
| Non‑synchronous bilateral metastatic ovarian cancer originating from small bowel adenocarcinoma with multidisciplinary treatment: A case report. | Oncol Lett | 2024 | 38192656 | PubTator, text mining | PubMed |
| Prognostic, diagnostic and clinicopathological roles of tsRNAs: a meta-analysis in breast cancer. | Eur J Med Res | 2024 | 38185655 | PubTator, text mining | PubMed |
| Primary mucinous adenocarcinoma of the urethra: A clinicopathological analysis of 35 cases. | Histopathology | 2024 | 38114291 | PubTator, text mining | PubMed |
| Loss of keratin 23 enhances growth inhibitory effect of melatonin in gastric cancer. | Mol Med Rep | 2024 | 38099343 | PubTator, text mining | PubMed |
| FOXP3-regulated lncRNA NONHSAT136151 promotes colorectal cancer progression by disrupting QKI interaction with target mRNAs. | J Cell Mol Med | 2024 | 38041531 | PubTator, text mining | PubMed |
| Cabozantinib for different endocrine tumours: killing two birds with one stone. A systematic review of the literature. | Endocrine | 2024 | 37851242 | PubTator, text mining | PubMed |
| Therapeutic efficacy of α-lactalbumin coated oleic acid based liposomes against colorectal carcinoma in Caco-2 cells and DMH-treated albino rats. | J Biomol Struct Dyn | 2024 | 37624964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=7